Medical management of Alagille syndrome.
Alagille syndrome is a highly variable, autosomal dominant disorder that affects the liver, heart, eyes, face, skeleton, kidneys, and vascular system. Much has been learned about the genetics of this disorder, which is caused primarily by mutations in the Notch signaling pathway ligand JAGGED1; however, the medical management of this condition is complex and continues to generate controversy. The significant variability of organ involvement requires the managing physician to have an understanding of the breadth and interplay of the variable manifestations. Furthermore, the liver disease in particular requires an appreciation of the natural history and evolution of the profound cholestasis.
Kamath
Binita M
BM
Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada. binita.kamath@sickkids.ca
Loomes
Kathleen M
KM
Piccoli
David A
DA
D016738:Alagille Syndrome / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D002135:Calcium-Binding Proteins / Q000235:genetics; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D036341:Intercellular Signaling Peptides and Proteins / Q000235:genetics; D000072100:Jagged-1 Protein; D008565:Membrane Proteins / Q000235:genetics; D009154:Mutation; D000072099:Serrate-Jagged Proteins
D002135:Calcium-Binding Proteins; D002756:Cholagogues and Choleretics; D036341:Intercellular Signaling Peptides and Proteins; C000606273:JAG1 protein, human; D000072100:Jagged-1 Protein; D008565:Membrane Proteins; D000072099:Serrate-Jagged Proteins